Mirion Technologies, Inc. (MIR) NYSE
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In USD
Address
1218 Menlo Drive
Atlanta, GA 30318
United States of America (the)
Phone
770 432 2744
Website
Sector
Industrials
Industry
Industrial - Machinery
Employees
2800
First IPO Date
August 20, 2020
| Name | Title | Pay | Year Born |
| Thomas D. Logan | Founder, Medical Group President, Chief Executive Officer & Chairman | 1.94M | 1961 |
| Alison Ulrich | Chief Human Resources Officer | 546,096 | N/A |
| Loic Eloy | Group President of Nuclear & Safety Technologies | 684,712 | 1977 |
| Emmanuelle Lee | Executive VP, Chief Legal Officer, Chief Compliance Officer & Secretary | 700,365 | N/A |
| Brian Schopfer | CFO & Medical Group President | 1.24M | 1985 |
| Erin Schesny | CMO & Senior Vice President of Government Affairs | 0 | N/A |
| Eric Linn | Vice President of Investor Relations | 0 | N/A |
| Shelia Webb | President of Nuclear Medicine | 0 | N/A |
| James Francis Charles Cocks | Chief Technology Officer | 0 | N/A |
| Marc Rubel | Chief Information Officer | 0 | N/A |
| Christopher Moore | Chief Accounting Officer | 0 | 1972 |
Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).